ArticleCurrent opinion in chemical engineering2011
Engineering nanosilver as an antibacterial, biosensor and bioimaging material.
Article in Current opinion in chemical engineering, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed.
- Potential of Silver Nanoparticles in Imaging Diagnostics and Image-Guided Applications: A Narrative Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Silver doped copper oxide decorated graphene oxide nanocomposite for electrochemical sensing, photocatalysis and biomedical applications.RSC advances · 2025Article
- Green synthesis of silver iodide nanoparticles from Kluyveromyces marxianus M59 beta-glucan: characterization and anticancer activity.BMC biotechnology · 2025Article
- Green Synthesis of Silver Nanoparticles Using Plant Extracts: A Comprehensive Review of Physicochemical Properties and Multifunctional Applications.International journal of molecular sciences · 2025Review
- Thermoplasmonic Nano-Hybrid Core@Shell Ag@SiONanomaterials (Basel, Switzerland) · 2025Article
- Review
- Silver Nanoparticles in Therapeutics and Beyond: A Review of Mechanism Insights and Applications.Nanomaterials (Basel, Switzerland) · 2024Review
- Silver/gold nanoalloy implant coatings with antibiofilm activityChemical communications (Cambridge, England) · 2024Article
- Dispersion and Dosimetric Challenges of Hydrophobic Carbon-Based Nanoparticles in In Vitro Cellular Studies.Nanomaterials (Basel, Switzerland) · 2024Article
- Recent Advances in Synergistic Effect of Nanoparticles and Its Biomedical Application.International journal of molecular sciences · 2024Review
- Optimizing nanosilver for implant success: from marketing hype to medical reality.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2024Review
- Advancing biological investigations using portable sensors for detection of sensitive samples.Heliyon · 2023Review
- Ag-lignin hybrid nanoparticles for high-performance solar absorption in photothermal antibacterial chitosan films.iScience · 2023Article
- Antiviral Activity of Active Materials: Standard and Finger-Pad-Based Innovative Experimental Approaches.Materials (Basel, Switzerland) · 2023Article
- Microwave Irradiation vs. Structural, Physicochemical, and Biological Features of Porous Environmentally Active Silver-Silica Nanocomposites.International journal of molecular sciences · 2023Article
- A Novel Ag@AgCl Nanoparticle Synthesized by Arctic Marine Bacterium: Characterization, Activity and Mechanism.International journal of molecular sciences · 2022Article
- Article
- SERS Hotspot Engineering by Aerosol Self-Assembly of Plasmonic Ag Nanoaggregates with Tunable Interparticle Distance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
- Antibiofilm activity of nanosilver coatings against Staphylococcus aureus.Journal of colloid and interface science · 2022Article
- The Mechanistic Action of Biosynthesised Silver Nanoparticles and Its Application in Aquaculture and Livestock Industries.Animals : an open access journal from MDPI · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The capacity of nanosilver (Ag nanoparticles) to destroy infectious micro-organisms makes it one of the most powerful antimicrobial agents, an attractive feature against "super-bugs" resistant to antibiotics. Furthermore, its plasmonic properties facilitate its employment as a biosensor or bioimaging agent. Here, the interaction of nanosilver with biological systems including bacteria and mammalian cells is reviewed. The toxicity of nanosilver is discussed focusing on Ag
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.